Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a randomized double-blind placebo-controlled study of ASP8302 in underactive bladder
2017-003693-13Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Detrusor hypocontractility and urinary retention comparing ASP8302 with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jul 2018; status: completed.
02
Drugs
ASP8302
03
Conditions
Detrusor hypocontractilityurinary retention
Beyond the preview
Go deeper on 2017-003693-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003693-13.